ASCENDIS HEALTH LIMITED - Dealings in securities by an associate of a director and notification in terms of section 122(3) of the Act

Dealings in securities by an associate of a director and notification in terms of section 122(3) of the Act

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis” or “the Company”)


Dealings in securities by an associate of a director and notification in terms of 
section 122(3) of the Companies Act and section 3.83(b) of the JSE Listing Requirements

Directors Dealings

In terms of paragraphs 3.63 to 3.74 of the Listings Requirements of the JSE Limited, the following
information, relating to dealings in securities by an associate of a director, is disclosed:

Name of director:                   Gary Shayne (non-executive)
Name of associate and               Gane Holdings Proprietary Limited (“Gane Holdings”). Gary
relationship with associate:        Shayne holds an indirect controlling shareholding in Gane
                                    Holdings through the ultimate holding company, Coast2Coast
                                    Communications Limited (“C2C”).
Nature of transactions:             On 02 March 2016, Gane Holdings, through wholly-owned
                                    subsidiaries of C2C, GaneFin9 (RF) Proprietary Limited and
                                    GaneFin10 (RF) Proprietary Limited, issued convertible
                                    debentures and, in terms of its contractual obligation, has
                                    now transferred Ascendis shares in settlement thereof,
                                    through off-market transfers. In terms of paragraph 3.70 of the
                                    JSE Listings Requirements, the JSE has granted a waiver in
                                    respect of dealings in the Company’s shares in a closed
                                    period by an associate of Mr G Shayne as the associate had
                                    no discretion in respect of these dealings due to the trades
                                    occurring as a result of a contractual obligation.
Nature and extent of interest:      Indirect beneficial
Class of shares:                    Ordinary shares
Written clearance obtained:         Clearance was obtained from the Chairman
Transaction 1:
Date of transaction:                12 February 2019
Number of shares:                   1,812,099
Price per share:                    R4.20
Value:                              R7,610,815.80
Transaction 2:
Date of transaction:                14 February 2019
Number of shares:                   1,812,099
Price per share:                    R4.20
Value:                              R7,610,815.80

Notification in terms of section 122(3) of the Companies Act and section 3.83(b) of the JSE
Listings Requirements

Shareholders of the Company are advised that C2C has disposed of a number of ordinary shares of
Ascendis, such that C2C now holds 19.32% of the total number of issued ordinary shares of
Ascendis. In terms of the requirements of the Companies Act No. 71 of 2008, Ascendis has filed the
required notices with the Takeover Regulation Panel.


Bryanston
19 February 2019

Sponsor
Questco Corporate Advisory Proprietary Limited

Date: 19/02/2019 01:45:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.